Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 483

1.

Complete mitochondrial genomes from transcriptomes: assessing pros and cons of data mining for assembling new mitogenomes.

Forni G, Puccio G, Bourguignon T, Evans T, Mantovani B, Rota-Stabelli O, Luchetti A.

Sci Rep. 2019 Oct 15;9(1):14806. doi: 10.1038/s41598-019-51313-7.

2.

Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging.

Cozzi A, Orellana DI, Santambrogio P, Rubio A, Cancellieri C, Giannelli S, Ripamonti M, Taverna S, Di Lullo G, Rovida E, Ferrari M, Forni GL, Fiorillo C, Broccoli V, Levi S.

Stem Cell Reports. 2019 Sep 27. pii: S2213-6711(19)30331-5. doi: 10.1016/j.stemcr.2019.09.002. [Epub ahead of print]

3.

Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience.

Pinto VM, Poggi M, Russo R, Giusti A, Forni GL.

Blood Rev. 2019 Aug 7:100594. doi: 10.1016/j.blre.2019.100594. [Epub ahead of print] Review.

PMID:
31416718
4.

Sickle cell disease: a review for the internist.

Pinto VM, Balocco M, Quintino S, Forni GL.

Intern Emerg Med. 2019 Oct;14(7):1051-1064. doi: 10.1007/s11739-019-02160-x. Epub 2019 Aug 5. Review.

PMID:
31385153
5.

Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project.

Hurle R, Colombo P, Lazzeri M, Lughezzani G, Buffi NM, Saita A, Elefante GM, Morenghi E, Forni G, Cardone P, Lista G, Maffei D, Guazzoni G, Casale P.

Eur Urol Oncol. 2018 Oct;1(5):437-442. doi: 10.1016/j.euo.2018.05.006. Epub 2018 Jun 5.

PMID:
31158085
6.

Mitochondrial genome diversity and evolution in Branchiopoda (Crustacea).

Luchetti A, Forni G, Skaist AM, Wheelan SJ, Mantovani B.

Zoological Lett. 2019 May 27;5:15. doi: 10.1186/s40851-019-0131-5. eCollection 2019.

7.

Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.

Russo G, De Franceschi L, Colombatti R, Rigano P, Perrotta S, Voi V, Palazzi G, Fidone C, Quota A, Graziadei G, Pietrangelo A, Pinto V, Ruffo GB, Sorrentino F, Venturelli D, Casale M, Ferrara F, Sainati L, Cappellini MD, Piga A, Maggio A, Forni GL.

Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0. Review.

8.

Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study.

Filippi L, Cavallaro G, Berti E, Padrini L, Araimo G, Regiroli G, Raffaeli G, Bozzetti V, Tagliabue P, Tomasini B, Mori A, Buonocore G, Agosti M, Bossi A, Chirico G, Aversa S, Fortunato P, Osnaghi S, Cavallotti B, Suzani M, Vanni M, Borsari G, Donati S, Nascimbeni G, Nardo D, Piermarocchi S, la Marca G, Forni G, Milani S, Cortinovis I, Calvani M, Bagnoli P, Dal Monte M, Calvani AM, Pugi A, Villamor E, Donzelli G, Mosca F.

Front Pediatr. 2019 May 7;7:180. doi: 10.3389/fped.2019.00180. eCollection 2019.

9.

Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study.

Cossu G, Abbruzzese G, Forni GL, Matta G, Pinto V, Ruffinengo U, Oppo V, Marchese R.

Neurol Sci. 2019 Jul;40(7):1357-1361. doi: 10.1007/s10072-019-03847-x. Epub 2019 Mar 22.

PMID:
30903420
10.

β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma.

Calvani M, Bruno G, Dal Monte M, Nassini R, Fontani F, Casini A, Cavallini L, Becatti M, Bianchini F, De Logu F, Forni G, la Marca G, Calorini L, Bagnoli P, Chiarugi P, Pupi A, Azzari C, Geppetti P, Favre C, Filippi L.

Br J Pharmacol. 2019 Jul;176(14):2509-2524. doi: 10.1111/bph.14660. Epub 2019 May 9.

PMID:
30874296
11.

Access to emergency departments for acute events and identification of sickle cell disease in refugees.

De Franceschi L, Lux C, Piel FB, Gianesin B, Bonetti F, Casale M, Graziadei G, Lisi R, Pinto V, Putti MC, Rigano P, Rosso R, Russo G, Spadola V, Pulvirenti C, Rizzi M, Mazzi F, Ruffo G, Forni GL.

Blood. 2019 May 9;133(19):2100-2103. doi: 10.1182/blood-2018-09-876508. Epub 2019 Feb 11. No abstract available.

PMID:
30745303
12.

Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.

Franchini M, Forni GL, Marano G, Cruciani M, Mengoli C, Pinto V, De Franceschi L, Venturelli D, Casale M, Amerini M, Capuzzo M, Grazzini G, Masiello F, Pati I, Veropalumbo E, Vaglio S, Pupella S, Liumbruno GM.

Blood Transfus. 2019 Jan;17(1):4-15. doi: 10.2450/2019.0229-18.

13.

Data in support for the measurement of heparan sulfate and dermatan sulfate by LC-MS/MS analysis.

Forni G, Malvagia S, Funghini S, Scolamiero E, Mura M, Bona MD, Villanelli F, Damiano R, la Marca G.

Data Brief. 2018 Nov 26;21:2398-2404. doi: 10.1016/j.dib.2018.11.100. eCollection 2018 Dec.

14.

Development of a fast LC-MS/MS protocol for combined measurement of six LSDs on dried blood spot in a newborn screening program.

Scolamiero E, Casetta B, Malvagia S, Tanigawa T, Forni G, Funghini S, Mura M, Raspini F, Poggiali S, la Marca G.

J Pharm Biomed Anal. 2019 Feb 20;165:135-140. doi: 10.1016/j.jpba.2018.12.002. Epub 2018 Dec 3.

PMID:
30530130
15.

Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study).

Lista G, Lughezzani G, Buffi NM, Saita A, Vanni E, Hurle R, Cardone P, Peschechera R, Forni G, Lazzeri M, Guazzoni G, Casale P.

Eur Urol Focus. 2018 Nov 6. pii: S2405-4569(18)30314-6. doi: 10.1016/j.euf.2018.10.013. [Epub ahead of print]

PMID:
30413390
16.

LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization.

Forni G, Malvagia S, Funghini S, Scolamiero E, Mura M, Della Bona M, Villanelli F, Damiano R, la Marca G.

Clin Chim Acta. 2019 Jan;488:98-103. doi: 10.1016/j.cca.2018.11.001. Epub 2018 Nov 2.

PMID:
30395869
17.

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.

Cappellini MD, Porter J, Origa R, Forni GL, Voskaridou E, Galactéros F, Taher AT, Arlet JB, Ribeil JA, Garbowski M, Graziadei G, Brouzes C, Semeraro M, Laadem A, Miteva D, Zou J, Sung V, Zinger T, Attie KM, Hermine O.

Haematologica. 2019 Mar;104(3):477-484. doi: 10.3324/haematol.2018.198887. Epub 2018 Oct 18.

18.

Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients.

Pinto VM, Balocco M, Quintino S, Bacigalupo L, Gianesin B, Rizzi M, Malagò R, De Franceschi L, Forni GL.

Am J Hematol. 2018 Oct;93(10):E338-E340. doi: 10.1002/ajh.25222. Epub 2018 Aug 14. No abstract available.

19.

Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guérin: experience of a single center.

Hurle R, Buffi N, Lista G, Cardone P, Forni G, Maffei D, Peschechera R, Zandegiacomo S, Pasini L, Benetti A, Colombo P, Lazzeri M, Casale P, Guazzoni G, Lughezzani G.

Minerva Urol Nefrol. 2018 Oct;70(5):501-508. doi: 10.23736/S0393-2249.18.03042-4. Epub 2018 Jul 3.

20.

Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited.

Derchi G, Dessì C, Bina P, Cappellini MD, Piga A, Perrotta S, Tartaglione I, Giuditta M, Longo F, Origa R, Quarta A, Pinto V, Forni GL; Webthal®.

Intern Emerg Med. 2019 Apr;14(3):365-370. doi: 10.1007/s11739-018-1890-2. Epub 2018 Jun 12.

PMID:
29948832
21.

{Health and work after invasive heart procedures, rehabilitation and occupational evaluation].

Scafa F, Calsamiglia G, Cadei P, Pettenuzzo E, Forni G, Candura SM.

Med Lav. 2018 Feb 28;109(3):219-24. doi: 10.23749/mdl.v109i3.6451. Italian.

PMID:
29943753
22.

Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias.

Origa R, Piga A, Tartaglione I, Della Corte G, Forni GL, Bruederle A, Castiglioni C, Han J.

Am J Hematol. 2018 Jul;93(7):E172-E175. doi: 10.1002/ajh.25122. Epub 2018 May 15. No abstract available.

23.

Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.

Russo R, Andolfo I, Manna F, Gambale A, Marra R, Rosato BE, Caforio P, Pinto V, Pignataro P, Radhakrishnan K, Unal S, Tomaiuolo G, Forni GL, Iolascon A.

Am J Hematol. 2018 May;93(5):672-682. doi: 10.1002/ajh.25058. Epub 2018 Feb 24.

24.

Serum creatinine during physiological perinatal dehydration may estimate individual nephron endowment.

Ardissino G, Tel F, Possenti I, Pavesi M, Perrone M, Forni G, Salice P, Colombo L, Ghirardello S, Castiglione B, Consonni D, Baca L, Vecchi DL, la Marca G, Mosca F.

Eur J Pediatr. 2018 Sep;177(9):1383-1388. doi: 10.1007/s00431-018-3087-0. Epub 2018 Feb 1.

PMID:
29387982
25.

Lack of correlation between heart, liver and pancreas MRI-R2*: Results from long-term follow-up in a cohort of adult β-thalassemia major patients.

Pinto VM, Bacigalupo L, Gianesin B, Balocco M, De Franceschi L, Malagò R, Wood J, Forni GL.

Am J Hematol. 2018 Mar;93(3):E79-E82. doi: 10.1002/ajh.25009. Epub 2018 Jan 9. No abstract available.

26.

Pseudoxanthoma Elasticum-Like in β-Thalassemia Major, a matter of α-Klotho and Parathyroid Hormone?

Baldan A, Giusti A, Bosi C, Malaventura C, Forni G, Borgna-Pignatti C.

Hemoglobin. 2017 Jul - Nov;41(4-6):254-259. doi: 10.1080/03630269.2017.1403927. Epub 2017 Dec 11.

PMID:
29226737
27.

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.

Rigano P, De Franceschi L, Sainati L, Piga A, Piel FB, Cappellini MD, Fidone C, Masera N, Palazzi G, Gianesin B, Forni GL; Italian Multicenter Study of Hydroxyurea in Sickle Cell Anemia Investigators.

Blood Cells Mol Dis. 2018 Mar;69:82-89. doi: 10.1016/j.bcmd.2017.08.017. Epub 2017 Oct 9.

28.

Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients.

Pinto VM, Gianesin B, Balocco M, Bacigalupo L, Forni GL.

Am J Hematol. 2017 Dec;92(12):E666-E668. doi: 10.1002/ajh.24918. Epub 2017 Oct 20. No abstract available.

29.

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.

Origa R, Ponti ML, Filosa A, Galeota Lanza A, Piga A, Saracco GM, Pinto V, Picciotto A, Rigano P, Madonia S, Rosso R, D'Ascola D, Cappellini MD, D'Ambrosio R, Tartaglione I, De Franceschi L, Gianesin B, Di Marco V, Forni GL; Italy for THAlassemia and hepatitis C Advance - Società Italiana Talassemie ed Emoglobinopatie (ITHACA-SITE).

Am J Hematol. 2017 Dec;92(12):1349-1355. doi: 10.1002/ajh.24911. Epub 2017 Oct 19.

30.

Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy.

Fonderico M, Laudisi M, Andreasi NG, Bigoni S, Lamperti C, Panteghini C, Garavaglia B, Carecchio M, Emanuele EA, Forni GL, Granieri E.

Front Neurol. 2017 Aug 21;8:385. doi: 10.3389/fneur.2017.00385. eCollection 2017.

31.

Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.

Colombatti R, Palazzi G, Masera N, Notarangelo LD, Bonetti E, Samperi P, Barone A, Perrotta S, Facchini E, Miano M, Del Vecchio GC, Guerzoni ME, Corti P, Menzato F, Cesaro S, Casale M, Rigano P, Forni GL, Russo G, Sainati L; Italian Multicenter Study of Hydroxyurea in Sickle Cell Anemia Investigators.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26774. Epub 2017 Sep 4.

PMID:
28868627
32.

Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project.

Hurle R, Lazzeri M, Vanni E, Lughezzani G, Buffi N, Casale P, Saita A, Morenghi E, Forni G, Cardone P, Lista G, Colombo P, Peschechera R, Pasini L, Zandegiacomo S, Benetti A, Maffei D, Vavassori I, Guazzoni G.

J Urol. 2018 Feb;199(2):401-406. doi: 10.1016/j.juro.2017.08.091. Epub 2017 Aug 26.

PMID:
28847481
33.

Is there a standard-of-care for transfusion therapy in thalassemia?

Franchini M, Forni GL, Liumbruno GM.

Curr Opin Hematol. 2017 Nov;24(6):558-564. doi: 10.1097/MOH.0000000000000373. Review.

PMID:
28719386
34.

Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.

Filippi L, Cavallaro G, Berti E, Padrini L, Araimo G, Regiroli G, Bozzetti V, De Angelis C, Tagliabue P, Tomasini B, Buonocore G, Agosti M, Bossi A, Chirico G, Aversa S, Pasqualetti R, Fortunato P, Osnaghi S, Cavallotti B, Vanni M, Borsari G, Donati S, Nascimbeni G, la Marca G, Forni G, Milani S, Cortinovis I, Bagnoli P, Dal Monte M, Calvani AM, Pugi A, Villamor E, Donzelli G, Mosca F.

BMC Pediatr. 2017 Jul 14;17(1):165. doi: 10.1186/s12887-017-0923-8.

35.

Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection.

Mangia A, Sarli R, Gamberini R, Piga A, Cenderello G, Piazzolla V, Santoro R, Caruso V, Quarta A, Ganga R, Copetti M, Forni G.

Aliment Pharmacol Ther. 2017 Aug;46(4):424-431. doi: 10.1111/apt.14197. Epub 2017 Jun 29.

36.

Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.

Kirk P, Sheppard M, Carpenter JP, Anderson L, He T, St Pierre T, Galanello R, Catani G, Wood J, Fucharoen S, Porter JB, Walker JM, Forni GL, Pennell DJ.

J Cardiovasc Magn Reson. 2017 Mar 27;19(1):36. doi: 10.1186/s12968-017-0349-3.

37.

Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.

Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G, Sorrentino F, D'Ascola DG, Spasiano A, Filosa A, Cuccia L, Dello Iacono N, Forni G, Caruso V, Maggio A, Pitrolo L, Peluso A, De Marchi D, Positano V, Wood JC.

Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):299-309. doi: 10.1093/ehjci/jex012.

PMID:
28200076
38.

The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.

Bandini S, Macagno M, Hysi A, Lanzardo S, Conti L, Bello A, Riccardo F, Ruiu R, Merighi IF, Forni G, Iezzi M, Quaglino E, Cavallo F.

Oncoimmunology. 2016 Nov 8;5(12):e1253653. doi: 10.1080/2162402X.2016.1253653. eCollection 2016.

39.

Patterns of CRISPR/Cas9 activity in plants, animals and microbes.

Bortesi L, Zhu C, Zischewski J, Perez L, Bassié L, Nadi R, Forni G, Lade SB, Soto E, Jin X, Medina V, Villorbina G, Muñoz P, Farré G, Fischer R, Twyman RM, Capell T, Christou P, Schillberg S.

Plant Biotechnol J. 2016 Dec;14(12):2203-2216. doi: 10.1111/pbi.12634. Epub 2016 Oct 11. Review.

40.

Comparison between different software programs and post-processing techniques for the MRI quantification of liver iron concentration in thalassemia patients.

Bacigalupo L, Paparo F, Zefiro D, Viberti CM, Cevasco L, Gianesin B, Pinto VM, Rollandi GA, Wood JC, Forni GL.

Radiol Med. 2016 Oct;121(10):751-62. doi: 10.1007/s11547-016-0661-2. Epub 2016 Jun 22.

PMID:
27334009
41.

Management of beta-thalassemia-associated osteoporosis.

Giusti A, Pinto V, Forni GL, Pilotto A.

Ann N Y Acad Sci. 2016 Mar;1368(1):73-81. doi: 10.1111/nyas.13041. Epub 2016 Apr 6. Review.

PMID:
27060977
42.

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

Di Marco V, D'Ambrosio R, Bronte F, Saracco G, Lanza AG, Forni G, Poggiali E, Calvaruso V; on behalf ITHACA (Italy for THAalassemia, hepatitis C Advances) Group.

Dig Liver Dis. 2016 Jun;48(6):650-5. doi: 10.1016/j.dld.2016.02.004. Epub 2016 Feb 21.

PMID:
27012446
43.

Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy.

Pinto V, Balocco M, Ambaglio I, Derchi G, Malcovati L, Forni GL.

Clin Case Rep. 2015 Nov;3(11):952-4. doi: 10.1002/ccr3.407. Epub 2015 Oct 21.

44.

Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry.

la Marca G, Giocaliere E, Malvagia S, Villanelli F, Funghini S, Ombrone D, Della Bona M, Forni G, Canessa C, Ricci S, Romano F, Guerrini R, Resti M, Azzari C.

Clin Chem Lab Med. 2016 Apr;54(4):627-32. doi: 10.1515/cclm-2015-0436.

PMID:
26466166
45.

Klotho, a new marker for osteoporosis and muscle strength in β-thalassemia major.

Baldan A, Giusti A, Bosi C, Malaventura C, Musso M, Forni GL, Volpato S, Zuliani G, Borgna-Pignatti C.

Blood Cells Mol Dis. 2015 Dec;55(4):396-401. doi: 10.1016/j.bcmd.2015.08.004. Epub 2015 Aug 24.

PMID:
26460265
46.

Coordinated logopedic and lingual-orthodontic treatment of an open-bite case.

Albertini E, Forni G, Lombardo L, Siciliani G.

J Clin Orthod. 2015 Jul;49(7):455-63. No abstract available.

PMID:
26267548
47.

Antitumor immunization of mothers delays tumor development in cancer-prone offspring.

Barutello G, Curcio C, Spadaro M, Arigoni M, Trovato R, Bolli E, Zheng Y, Ria F, Quaglino E, Iezzi M, Riccardo F, Holmgren L, Forni G, Cavallo F.

Oncoimmunology. 2015 Feb 3;4(5):e1005500. eCollection 2015 May.

48.

Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes.

Balleari E, Salvetti C, Del Corso L, Filiberti R, Bacigalupo A, Bellodi A, Beltrami G, Bergamaschi M, Berisso G, Calzamiglia T, Carella AM, Cavalleri M, Da Col A, Favorini S, Forni GL, Goretti R, Miglino M, Mitscheuning L, Molinari E, Racchi O, Scudeletti M, Tassara R, Gobbi M, Lemoli R, Clavio M.

Leuk Res. 2015 Aug;39(8):846-52. doi: 10.1016/j.leukres.2015.05.007. Epub 2015 Jun 22.

PMID:
26145790
49.

Vaccines for tumor prevention: a pipe dream?

Forni G.

J Infect Dev Ctries. 2015 Jul 4;9(6):600-8. doi: 10.3855/jidc.7201. Review.

50.

Expanded newborn screening by mass spectrometry: New tests, future perspectives.

Ombrone D, Giocaliere E, Forni G, Malvagia S, la Marca G.

Mass Spectrom Rev. 2016 Jan-Feb;35(1):71-84. doi: 10.1002/mas.21463. Epub 2015 May 7. Review.

PMID:
25952022

Supplemental Content

Support Center